EA2192: APOLLO - A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Adjuvant Chemotherapy in Patients with Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Objective

Clinical Trial Details >>

Principal Investigator(s)

Heidi McKean, MD

Clinical Trial Categories

• Pancreatic Cancer

Contact

Medical Oncology Research Coordinators at 605-322-3295
or medoncresearch@avera.org